Attached files
file | filename |
---|---|
EX-99.1 - EXHIBIT 99.1 - WALGREEN CO | a6124807ex991.htm |
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of
Report (Date of earliest event reported): December 21, 2009
WALGREEN
CO.
(Exact
name of registrant as specified in its charter)
Illinois
|
1-604
|
36-1924025
|
||
(State
or other jurisdiction of incorporation)
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
200
Wilmot Road, Deerfield, Illinois
|
60015
|
|
(Address
of principal executive offices)
|
(Zip
Code)
|
Registrant’s
telephone number, including area code: (847) 940-2500
Not
Applicable
(Former
name or former address, if changed since last report)
Check the
appropriate box below if the Form 8-K filing is intended to simultaneously
satisfy the filing obligation of the registrant under any of the following
provisions:
o
|
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
|
o
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
|
o
|
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))
|
o
|
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))
|
Item
2.02 Results
of Operations and Financial Condition.
On
December 21, 2009, Walgreen Co. issued a press release announcing financial
results for the quarter ended November 30, 2009. A copy of this press
release is attached hereto as Exhibit 99.1.
This
information, including exhibits attached hereto and the information under Item
7.01 below, shall not be deemed “filed” for purposes of Section 18 of the
Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise
subject to the liabilities of that section. This information shall
not be deemed to be incorporated by reference in any filing under the Securities
Act of 1933, as amended, or the Exchange Act, except as shall be expressly set
forth by specific reference to this Form 8-K in such a filing.
Item
7.01 Regulation
FD Disclosure.
In
addition to issuing a press release, Walgreen Co. is also conducting a
conference call and webcast regarding results for the quarter ended November 30,
2009. Slides prepared for the purposes of the conference call are
available on the Walgreens investor relations Web site at
http://investor.walgreens.com.
Item
9.01 Financial
Statements and Exhibits.
The
following exhibit is being furnished as part of this Form 8-K:
Exhibit Number
|
Exhibit Title
|
|
99.1
|
Press
Release issued by Walgreen Co. on December 21, 2009, announcing results
for the quarter ended November 30,
2009.
|
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
WALGREEN
CO.
|
|||
Date:
December 21, 2009
|
By:
|
/s/
Wade D. Miquelon
|
|
Name:
Wade D. Miquelon
|
|||
Title:
Executive Vice President and Chief Financial
Officer
(Principal Financial Officer)
|
|||
2